Skip to content
healthcare.dev

TREE ANTIGEN

NDC 43406-0126, Populus Tristis Pollen, Juglans Nigra Pollen, Acer Negundo Pollen, Alnus Rubra Pollen, Juniperus Virginiana Pollen, Ulmus Rubra Pollen, Acer Pseudoplanus Pollen, Fraxinus Americana Pollen, Carya Tomentosa Pollen, Onion, Arsenic Trioxide, Atropa Belladonna, Activated Charcoal, Euphrasia Officinalis, Lycopodium Clavitum Spore, Sodium Chloride, Strychnos Nux-Vomica Seed, Pulsitilla Vulgaris Whole, liquid, from Natural Creations, Inc.

Product NDC
43406-0126
Status
Listed
Labeler
Natural Creations, Inc
Dosage form
LIQUID
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/43406-0126 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • POPULUS TRISTIS POLLEN30 [hp_X]/mL
  • JUGLANS NIGRA POLLEN30 [hp_X]/mL
  • ACER NEGUNDO POLLEN30 [hp_X]/mL
  • ALNUS RUBRA POLLEN30 [hp_X]/mL
  • JUNIPERUS VIRGINIANA POLLEN30 [hp_X]/mL
  • ULMUS RUBRA POLLEN30 [hp_X]/mL
  • ACER PSEUDOPLATANUS POLLEN30 [hp_X]/mL
  • FRAXINUS AMERICANA POLLEN30 [hp_X]/mL
  • CARYA TOMENTOSA POLLEN30 [hp_X]/mL
  • ONION30 [hp_C]/mL
  • ARSENIC TRIOXIDE30 [hp_C]/mL
  • ATROPA BELLADONNA30 [hp_C]/mL
  • ACTIVATED CHARCOAL30 [hp_C]/mL
  • EUPHRASIA OFFICINALIS LEAF30 [hp_C]/mL
  • LYCOPODIUM CLAVATUM SPORE30 [hp_C]/mL
  • SODIUM CHLORIDE30 [hp_C]/mL
  • STRYCHNOS NUX-VOMICA SEED30 [hp_C]/mL
  • PULSATILLA VULGARIS30 [hp_C]/mL

Pharmacologic classes

Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Non-Standardized Food Allergenic Extract [EPC]; Non-Standardized Plant Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Plant Proteins [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Seed Storage Proteins [CS]; Vegetable Proteins [CS]

Package NDCNDC-11Package
43406-0126-14340601260130 mL in 1 BOTTLE, DROPPER (43406-0126-1)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 43406-0126 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/43406-0126 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 43406-0126. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.